Stocks Health care MDXG
NASDAQ · Health careMimedx Group, Inc. (MDXG)
Mimedx Group, Inc. brought in $303.7M of revenue over the twelve months to September 30, 2026, down 22.8% from a year earlier. It posted a net loss of $19.2M. At September 30, 2026 it held $120.8M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on October 28, 2026.
Key facts about Mimedx Group, Inc.
- Net worth
- Mimedx Group, Inc. has a market value (market cap) of $483.9M at the latest share price, and shareholders' equity of $211.1M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $418.6M (+20.0% year on year), with net income of $48.6M. Over the 12 months to September 30, 2026: revenue $303.7M, net loss $19.2M.
- Cash flow
- In fiscal 2025 operations brought in $74M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on October 28, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- Mimedx Group, Inc.'s next report is expected around February 24, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What Mimedx Group, Inc. does
Mimedx Group, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker MDXG.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $418.6M | $48.6M | $0.32 | n/a |
| 2024 | $348.9M | $42.4M | $0.28 | n/a |
| 2023 | $321.5M | $58.2M | $0.37 | $24.8M |
| 2022 | $267.8M | -$30.2M | -$0.33 | -$19.4M |
| 2021 | $242M | -$10.3M | -$0.15 | -$5.2M |
| 2020 | $248.2M | -$49.3M | -$0.77 | n/a |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where MDXG ranks in Health care
Latest SEC filings
What Mimedx Group, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- October 28, 2026Form 425 filing 425
- October 28, 2026
- October 28, 2026Quarterly report 10-Q · period to September 30, 2026Revenue fell 45% to $62.3M versus the same quarter last year; diluted EPS -$0.06 versus $0.11.
- October 16, 2026Form 425 filing 425
- October 16, 2026Other event 8-K
- August 25, 2026
- August 11, 2026Form 425 filing 425
- August 11, 2026Material agreement 8-K/A
- July 30, 2026Form 425 filing 425
- July 30, 2026Form 425 filing 425
Insider trades
What the people running Mimedx Group, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| July 2, 2026 | Doug RiceChief Financial Officer | Shares withheld for tax | 12,749 | $50.4K |
| June 24, 2026 | Maersk-Moller KimberlyChief Commercial Officer | Shares withheld for tax | 19,820 | $75.9K |
| June 10, 2026 | Olson TiffanyDirector | Received as pay | 50,913 | $185.3K |
| June 10, 2026 | Hawkins William ADirector | Received as pay | 50,913 | $185.3K |
| June 10, 2026 | Newton ToddDirector | Received as pay | 50,913 | $185.3K |
| June 10, 2026 | Puhy Dorothy EDirector | Received as pay | 50,913 | $185.3K |
| June 10, 2026 | Bierman James LDirector | Received as pay | 50,913 | $185.3K |
| March 13, 2026 | Hulse William Frank IVGeneral Counsel and CAO | Shares withheld for tax | 20,245 | $88.7K |
Who owns MDXG
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Martin P. Sutter13D, may seek influence with 5 related filers | 19.3% | December 27, 2023 |
Largest institutional holders
Insiders
10 insiders reported holding 3,819,191 shares in total, about $12.7M at the last price.
| Holder | Shares |
|---|---|
| Capper Joseph HChief Executive Officer | 904,656 |
| Hulse William Frank IVGeneral Counsel and CAO | 543,195 |
| Newton ToddDirector | 463,684 |
| Whitlow Ricci SChief Operating Officer | 462,825 |
| Doug RiceChief Financial Officer | 399,566 |
| Maersk-Moller KimberlyChief Commercial Officer | 309,630 |
| Bierman James LDirector | 263,684 |
| Hawkins William ADirector | 254,931 |
| Olson TiffanyDirector | 108,510 |
| Puhy Dorothy EDirector | 108,510 |
Questions about MDXG
What does Mimedx Group, Inc. do?
Mimedx Group, Inc. is a company in the Health care sector, listed on NASDAQ as MDXG. Its shares trade on NASDAQ under the ticker MDXG.
What is Mimedx Group, Inc.'s net worth?
Mimedx Group, Inc. has a market value (market cap) of $483.9M at the latest share price, and shareholders' equity of $211.1M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Mimedx Group, Inc. profitable?
No. Over the twelve months to September 30, 2026 it reported a net loss of $19.2M on revenue of $303.7M.
How much revenue does Mimedx Group, Inc. make?
Over the twelve months to September 30, 2026 Mimedx Group, Inc. reported revenue of $303.7M. That is 22.8% less than a year earlier.
When did Mimedx Group, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on October 28, 2026. It covers the period to September 30, 2026.
When is Mimedx Group, Inc.'s next earnings report?
Mimedx Group, Inc.'s next report is expected around February 24, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare MDXG with
Follow MDXG
Get an email when Mimedx Group, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Mimedx Group, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.